HCW Biologics Inc.
HCWB
$7.05
-$0.58-7.60%
NASDAQ
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 30.03% | -91.10% | -93.33% | -85.54% | -88.79% |
Total Receivables | -62.09% | -8.21% | -7.38% | 257.70% | 267.68% |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | -68.51% | -79.56% | -70.15% | -30.84% | -25.27% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -50.84% | -49.63% | -49.68% | 37.95% | 17.81% |
Total Current Assets | -11.02% | -84.88% | -87.95% | -79.26% | -81.20% |
|
|||||
Total Current Assets | -11.02% | -84.88% | -87.95% | -79.26% | -81.20% |
Net Property, Plant & Equipment | 12.01% | 53.76% | 79.10% | 89.96% | 89.30% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -49.56% | -99.46% | -99.47% | -72.14% | -83.08% |
Total Assets | 6.04% | -25.44% | -32.07% | -30.11% | -39.09% |
|
|||||
Total Accounts Payable | 262.11% | 618.69% | 697.54% | 801.03% | 402.95% |
Total Accrued Expenses | -59.64% | -50.14% | 181.01% | 27.27% | 56.73% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -33.09% | -40.70% | -- | -17.13% |
Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
Total Other Current Liabilities | -- | -- | -- | -- | -- |
Total Current Liabilities | 238.71% | 455.01% | 411.67% | 196.61% | 195.88% |
|
|||||
Total Current Liabilities | 238.71% | 455.01% | 411.67% | 196.61% | 195.88% |
Long-Term Debt | 17.03% | 2.05% | 55.68% | 29.57% | -1.65% |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 145.86% | 210.88% | 203.92% | 98.68% | 60.46% |
|
|||||
Common Stock & APIC | 11.66% | 4.17% | 4.17% | 4.22% | 1.24% |
Retained Earnings | -42.57% | -62.37% | -69.87% | -54.12% | -54.89% |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | -150.29% | -141.77% | -122.04% | -73.20% | -64.03% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -150.29% | -141.77% | -122.04% | -73.20% | -64.03% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -150.29% | -141.77% | -122.04% | -73.20% | -64.03% |
|